首页> 外文期刊>Biometrika >Targeted learning ensembles for optimal individualized treatment rules with time-to-event outcomes
【24h】

Targeted learning ensembles for optimal individualized treatment rules with time-to-event outcomes

机译:针对最佳个性化治疗规则的有针对性的学习合作与事件发生的结果

获取原文
获取原文并翻译 | 示例
           

摘要

We consider estimation of an optimal individualized treatment rule when a high-dimensional vector of baseline variables is available. Our optimality criterion is with respect to delaying the expected time to occurrence of an event of interest. We use semiparametric efficiency theory to construct estimators with properties such as double robustness. We propose two estimators of the optimal rule, which arise from considering two loss functions aimed at directly estimating the conditional treatment effect and recasting the problem in terms of weighted classification using the 0-1 loss function. Our estimated rules are ensembles that minimize the crossvalidated risk of a linear combination in a user-supplied library of candidate estimators. We prove oracle inequalities bounding the finite-sample excess risk of the estimator. The bounds depend on the excess risk of the oracle selector and a doubly robust term related to estimation of the nuisance parameters. We discuss the convergence rates of our estimator to the oracle selector, and illustrate our methods by analysis of a phase III randomized study testing the efficacy of a new therapy for the treatment of breast cancer.
机译:我们考虑当基线变量的高维向量可用时估计最佳个性化治疗规则。我们的最优标准是关于延迟发生感兴趣事件的预期时间。我们使用Semiparametric效率理论来构建具有双重稳健性等性质的估算器。我们提出了两种最佳规则的估算,这意味着考虑到两种损失函数,旨在使用0-1损耗函数在加权分类方面重新估算条件治疗效果并重铸问题。我们的估计规则是最小化在用户提供的候选估算库中的线性组合的交叉验证风险的合奏。我们证明了Oracle不平等限制了估算器的有限样本风险。界限取决于Oracle选择器的过度风险和与估计滋扰参数的双重稳健术语。我们讨论我们估计器到Oracle选择器的收敛速率,并通过分析III期随机研究测试新治疗治疗乳腺癌的疗效来说明我们的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号